Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

N/ACompletedNCT00518141

Sykehuset Telemark300 enrolled

Overview

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

300

Conditions

Reproductive Techniques, Assisted

Interventions

Acetyl Salicylic Acid and TerbutalinDRUG

ASA 75 mg, Terbutalin 5mg

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 39 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Infertile women below 39 years of age Exclusion Criteria: * Women who may react allergically to the drugs administered * Women with hyperthyroid or IDDM * Women who do not want to participate in the study * Women who are unable to give informed, written consent.

Locations (1)

STHF, Kvinneklinikken, Fertilitetsklinikken Sor

Porsgrunn, Telemark, Norway

Outcomes

Primary Outcomes

Pregnancy

Time frame: 7 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.